ing nerves after significant segmental injury. The use of nerve allografts (a graft derived from donors of the same species) represents a valid alternative to autografting because allografts shorten the time of surgery and supply long grafts that enable preservation of cell viability over an extended time period. 2, 9 The use of allografts from cadaveric donors has attracted renewed interest in recent years, and allograft pretreatment with cryopreservation in combination with immunosuppression has been shown to maximize axonal regrowth and minimize allograft rejection in experimental models. 16 Previous studies have demonstrated that cryopreservation and controlled freezing can decrease the immune response and graft rejection in patients undergoing procedures aimed at preserving Schwann cell viability. 9 In 2007, we therefore began using a novel surgical technique for peripheral nerve reconstruction with cryopreserved allografts recovered from selected cadaveric donors and provided by the tissue bank of Treviso.
The purpose of this study was to assess the outcomes of treatments of brachial plexus stretch injuries that are based on implantation of nerve allografts from cadaveric donors and whether cryopreservation of these allografts eliminates the need for immunosuppressive therapy. Moreover, we confirmed that EMG testing performed before surgery (to locate and identify the type of peripheral nerve lesions), intraoperatively (to map functional integrity of nerves and choose the best surgical approach), and postoperatively is the best strategy to comprehensively monitor nerve function in patients.
Methods

Patients and Clinical Assessments
This clinical study was approved by the Ethical Committee of the Ospedale dell'Angelo, and the patients gave their written informed consent to the surgical intervention and to the use of a cryopreserved allograft from a cadaveric donor. Ten patients with peripheral upper-limb lesions and no significant clinical and electrophysiological recovery (that is, without any sign of ongoing reinnervation on EMG testing) were included in this study (see Table 1 ). The type of trauma in all patients was traction injury caused by motor vehicle accidents. Patients were clinically examined and underwent EMG testing 1 and 3 months after the trauma and 1 week before the surgery (Table 1) . Of these patients, 8 displayed whole or partial lesions of the brachial plexus and 2 exhibited injuries to single or motor-branch nerves. Neurotmesis was suspected in 8 patients, and in the other 2 patients, the presence of neurogenic potentials without significant reinnervation indicated axonotmetic lesions. All patients underwent IOM using the Protektor Device (XLTEK): NAPs were recorded using hook electrodes for recording and a tripolar electrode for stimulation. If a NAP was present (indicating functional continuity of a nerve), external neurolysis was performed. If a NAP was absent (diagnosed as neurotmesis), nerve neurotization (direct or by means of nerve transfer) was performed if the nerve damage was proximal. In cases of loss of the distal stump of a motor nerve, muscular neurotization was accomplished through a well-described technique. 6 Only allografts from cadavers were used, and none of the patients underwent immunosuppressive treatment. Neurological examinations of motor tasks using the MRC scale and neurophysiological follow-ups were performed after 6 months, 1 year, and 2 years. This work was carried out in collaboration with the Treviso tissue bank, which, in 2006, began recovering nerves from cadaveric donors for clinical use in allotransplantation.
Recovery, Processing, and Cryopreservation of Nerve Grafts
Graft donors were selected according to strict criteria to minimize the risk of exposing nerve-allograft recipients to transmissible diseases. Serological tests for detecting hepatitis B and C viruses, HIV, cytomegalovirus, human T-cell lymphotropic virus, or the syphilis pathogen, along with polymerase chain reaction for detecting HIV and hepatitis B and C viruses, were performed on the donor's plasma. Upon recovery, nerve tissues were immersed in antibiotic solution for decontamination and underwent longitudinal microbiological testing during processing: if a microbiological culture yielded microbial growth, the tissue was discarded. Before the freezing, tissues were immersed in a storage solution composed of RPMI1640 with L-glutamine (Sigma-Aldrich) containing 10% dimethyl sulfoxide as cryoprotectant (Sigma-Aldrich) and 2% of human albumin (Kedrion). Dimethyl sulfoxide quickly penetrates the cells, links to water molecules, and results in a liquid phase preventing the formation of ice crystals, 4 which cause mechanical stress on cell walls and can damage the cells. At very low temperatures, all biological processes and chemical reactions are essentially suspended while the cell architecture is preserved. Each tissue was preserved in 2 sterile, low temperature-resistant polypropylene bags and placed in a liquid nitrogen computer-controlled freezer (ICECUBE 1860) that facilitates a controlled decrease in temperature (1°C/minute) to -140°C. After the freezing, the tissues were stored at between -140°C and -160°C in vapor of liquid nitrogen.
Allografts were usually collected from the lower limbs of human cadavers and were stored according to their diameter and length and requested on the basis of their dimensions. Before use, the nerves were thawed at 4°C, and their structural integrity was confirmed by histological analysis. The mean length of cryopreservation of the grafts before implantation was 9 months. To assess the cellular and structural integrities of the cryopreserved tissues, their macro-and ultrastructure were compared with those of nerve samples (from the brachial plexus) obtained within 24 hours after cardiac arrest from 4 age-matched individuals (2 male and 2 female) who had died of nonneurological pathologies.
Surgical Technique
Thus far, we have surgically treated 51 patients with allografts from cadaveric donors, and here we describe the surgical intervention and follow-up of the first 10 patients.
The surgical technique for allografts was similar to that for autografts, except for the preferential use of the fascicular graft because the epineurium from cadavers is thinner and more delicate. In most cases, the brachial plexus was explored through supra-and infraclavicular approaches. Direct neurotization with graft repair was performed when the proximal part of the nerve trunk was noncontinuous and the nerve stumps could not be opposed well enough for end-to-end repair. Nerve transfers were used for more proximal lesions when a tension-free endto-end coaptation was not possible or in the case of a longer distance from the target motor end plates. 21 The most commonly used nerves were the medial/lateral pectoral or spinal accessory nerves; 22 in some patients, in case of loss of the distal stump of a motor nerve or avulsion of the neural part of muscles, an extensive muscular neurotization through intra-and extraplexus nerve transfer was performed according to the technique described by Brunelli.
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Results
In total, 21 EMG recordings were performed in the patients of this study (Table 2 ; note that multiple recordings and nerve reconstructions were performed in some of these patients). A NAP was recorded in 5 nerves, whereas in the remaining 16 recordings, no NAP was detected. In total, 7 muscular neurotizations and 7 nerve neurotizations (2 direct neurotizations and 5 nerve transfers) and 5 neurolysis procedures were performed, and 14 allografts from cadaveric donors were implanted. Table 2 summarizes the length of time between the traumatic event and surgery, the IOM data, and the surgical strategy used according to the functional continuity of nerves (indicated by the presence of an NAP). The type of surgery performed and the length of the nerve graft used are detailed in Table 3 . Figure 1 shows an example of nerve neurotization and nerve transfer (a lateral pectoral nerve with an axillary nerve and a medial pectoral nerve with a musculocutaneous nerve) with interposition of cryopreserved allografts (from a femoral nerve) in Case 4.
The results of clinical examinations at 1 week before nerve-reconstructive surgery and at the 2-year follow-up are shown in Table 4 . All of the patients displayed improvements in motor function after the surgery, demonstrated by an increase in the MRC to scores equal to or greater than 3 at the 2-year follow-up compared with MRC scores of equal to or lower than 1 before the surgery.
As shown in Fig. 2 , we observed a compound motor action potential from deltoid muscle after stimulating the accessory nerve in Case 6, possibly because of postsurgery reinnervation after end-to-side nerve transfer with grafting. This is in agreement with recent evidence from an experimental brachial plexus rat model, indicating donor nerve reinnervation and collateral sprouting of axons.
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Discussion
The management of brachial plexus injuries is challenging because treatment approaches rely on appropriate selection of patients for the surgery, and the optimal surgical procedure has to be determined on the basis of intraoperative findings. Among the many prognostic factors for good surgical outcomes are the type of peripheral nerve lesion (axonotmesis or neurotmesis), the injury level (proximal regeneration versus distal), and the distance of the nerve lesion to the muscle (a longer distance may delay recovery because of axonal misdirection). Among prognostic factors, the time between trauma and operation (< 6 months), intraoperative findings (presence of a NAP), and surgical techniques (autograft or allograft) are the most relevant.
In the last few years, cooperation between neurosurgeons and neurophysiologists has improved the management of brachial plexus surgery. Electrophysiology can provide data for choosing patients who show no signs of ongoing reinnervation at preoperative EMG testing, for selecting the best surgical strategy intraoperatively, and for quantifying the recovery at clinical follow-ups. Moreover, IOM provides information for deciding on the most appropriate surgical strategy: if an NAP is absent, direct neurotization, nerve transfer, or muscular neurotization (if damage is proximal) possibly with nerve grafting 8 is recommended.
Nerve allotransplantation (implantation) has been successfully used in patients to restore function after traumatic nerve injury. Autologous nerve grafting is considered the gold standard for repair of nerve gaps, acting as a scaffold and providing viable Schwann cells that produce neurotrophic factors for axonal regeneration. 10, 11, 20 Synthetic or viable biological nerve conduits represent an interesting area of research, but their use is limited to short nerve gaps and small nerve injuries (approximately 2 cm in length). Recently, allografts from human cadavers have attracted renewed interest. Nerve allotransplantation acts as a viable biological conduit and provides a temporary scaffold for regeneration of host nerves. Allografts have some advantages over autografts: the use of allografts is less time consuming in surgery and may provide better nerve samples (in terms of quantity and caliber), and it requires no surgical adaptation of the diameter stump between donor and recipient nerves. On the basis of these considerations, we believe that cadaveric allografts provide an unlimited supply of nerve tissues of varying length and diameter. Another important advantage of this new technique is the absence of morbidities, such as sensory paresthesia, neuroma, or scar formation, that are often associated with autologous grafts and are caused by the explanting procedure.
Treatment with cryoprotectant agents, a proper cooling rate, and appropriate storage and thawing conditions are necessary prerequisites for a successful cryopreservation of allografts. This cold preservation method may provide an almost unlimited supply of graft material to be used in peripheral nerve reconstruction and enables long-term storage of the grafts. 10, 13, 20 The roles of tissue processing and cryopreservation in immunogenicity have been a matter of debate: several studies in animals have demonstrated that cryopreservation and controlled freezing decrease the immune response and risk of graft rejection in recipients, preserve Schwann cell viability, and maintain the nerve basal lamina. These techniques have been also shown to decrease the expression of Class II HLAs (human leukocyte antigens) and intercellular adhesion molecule-1, which are essential for immunological recognition of foreign tissues, and this decreased expression supports axonal regeneration across short peripheral nerve gaps. 1, 9, 10, 13, 20 Other authors have failed to demonstrate axonal elongation after cryopreservation of longsegment allografts (8 cm in length). 26 The freeze-thawing process seems to leave perineurial and endoneurial connective tissues intact, effectively preventing infiltration by host lymphocytes as has been observed in fresh allografts and allowing nerve regeneration similar to that observed for autografts, as assessed by qualitative histology. 9 Moreover, experimental studies in rats and primates have demonstrated that immunosuppressive therapies (for example, with tacrolimus or cyclosporine A) maximize axonal regrowth and prevent rejection of the donor nerve 3, 12, 15, 16 when used alone or when combined with allograft pretreatment. 16, 25 In humans, Mackinnon and coauthors 18 reported good recoveries of motor and sensory functions in 6 patients who had undergone peripheral reconstruction of nerve gaps with immunosuppression. However, longterm systemic immunosuppression may increase the risks of malignancies and opportunistic infections. 16 An attractive alternative to cryopreserved nerve allografts are processed acellular allografts, which, in animal studies, have shown similarity to isografts and superiority to collagen tubes. 28 These acellular allografts are processed and decellularized to maintain an extracellular matrix of laminin and intact endoneurial tubes that does not generate an immune response and acts as a bridge to guide the regenerating axons in the recipient's tissue. A recent multicenter study involving 108 adult patients who had undergone peripheral surgical reconstruction showed that the use of acellular allografts results in significant recovery without graft-related adverse events. 5 Nevertheless, similar to artificial conduits, processed allografts have effective length restrictions-although Neubauer and coworkers recently demonstrated that 4-cm frozenthawed decellularized allografts support nerve regeneration when pretreated with chondroitinase, 19 and Brooks and colleagues 5 successfully used acellularized grafts with a maximum length of 5 cm for nerve reconstruction.
In our study, we have reconstructed damaged nerves with cryopreserved cadaveric allografts with a maximum length of 10 cm and without suppressing the immune responses in the recipients. Histological examinations of the allografts after thawing confirmed the structural integrity of the cryopreserved grafts, and all of our patients treated with these allotransplants showed clinical and neurophysiological improvements and did not present any apparent rejection reactions at the 1-and 2-year follow-ups. Previous studies have demonstrated that increasing the extent of cold preservation (up to 7 weeks) reduces cellular immune responses and does not affect the regeneration of nerves. Table 1 ).
Fig. 2.
A needle recording of the deltoid muscle after accessory stimulation indicates reinnervation of the muscle after surgical reconstruction.
In our series, the nerve allografts were stored at temperatures between -140°C and -160°C in liquid nitrogen for a mean period of 9 months before being implanted. These storage temperatures and time periods are lower and longer, respectively, than those reported in the experimental studies. Mackinnon and coworkers reported the outcomes of immunosuppression and transplantation with allografts stored at a higher temperature (5°C) and for a shorter time (7 days) than in the present study. 18 These authors' results suggested that pretreating the allografts at lower temperatures for longer periods may result in an attenuated immune response, preventing rejection of the allograft and facilitating axonal regeneration.
Because we did not test the viability of the Schwann cells after the thawing of the allografts, we do not know whether these cells participate in the neuroregeneration process. However, the good preservation of the morphological features of our grafts observed in the histological examination strongly suggests that the grafts may act as a bridge crossing the structures of the extracellular matrix (including basal lamina, endoneurial tubes, and laminin). This bridge may provide a 3D scaffold that guides and supports the regenerating axons for greater lengths than can be achieved with acellularized grafts. However, the relationship between the length of the nerve graft and clinical recovery is not straightforward, 27 probably because of the presence of several covariates among patients, such as the patients' age, lengths of the nerve gaps, and surgical approaches.
Conclusions
Although variables such as age, associated vascular and bone injuries, nerve lesion type, and time since injury may affect functional recovery from nerve injuries, the outcome of nerve-reconstructive surgeries is more favorable when patients are carefully evaluated and selected for the surgery.
In this regard, preoperative neurophysiology testing is the best approach to reveal any pathophysiology and locate the level of nerve injury. In particular, IOM is mandatory for reliable determination of the type of nerve lesion and for selecting surgical strategies. Nerve autografting represents a classic conventional approach that provides only small amounts of nerve tissues for use in reconstructive surgery. In contrast, nerve allografts from cadaveric donors provide a wide range of graft materials for reconstructive procedures and avoid drawbacks related to autologous grafts, such as sensory paresthesia, neuroma, or scar formation. Prolonged cold storage of these allografts provides additional advantages: it facilitates better planning of surgeries, provides an almost unlimited supply of nerve grafts, and reduces immunogenicity through freezethawing and cryopreservation.
Like other retrospective studies, our study has some limitations: in addition to a small sample size and the lack of a control group, these include the use of a heterogeneous group of subjects, differences in the extent and types of injuries in these patients, and variation in the length of nerve grafts and the length of time between trauma and surgery. It is of note that the goal of this study was not to demonstrate the superiority of one method over another (that is, to compare the use of cadaveric allografts with that of acellularized grafts or autografts). Rather, this study's objective was to point out the importance of careful patient evaluation before surgery and the use of an appropriate surgical strategy based on IOM findings. In addition to the use of cadaveric allografts, the successful outcomes in these patients can also be explained by a number of additional factors. First, the patients did not present a complete plexus lesion, so it was possible to perform intraplexus nerve transfer and sometimes double neurotization. Second, the patients of our cohort were young and were admitted to our hospital within 6 months of the trauma, both of which are prognostic factors for a favorable outcome. Third, a careful preoperative and intraoperative patient evaluation, along with a close collaboration with the tissue bank and the use of a multidisciplinary approach, contributed to the successful completion of the plexus surgeries.
We also demonstrated that prolonged cryopreservation of allografts from cadaveric donors is a valid surgical strategy to restore the function of the damaged nerve without the need for any immunosuppressive treatments. Therefore, this approach represents an intriguing alternative to autografting for nerve defects over gap distances longer than 5 cm and offers new perspectives on methods for extensive nerve reconstructions in brachial and lumbosacral plexuses.
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